Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032

Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032

Including: 1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis3) By End-User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research FacilitiesCovering: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation (Cepheid Inc.)


Tuberculosis Diagnostics Global Market Opportunities And Strategies To 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global tuberculosis diagnostics market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Description:

Where is the largest and fastest-growing market for tuberculosis diagnostics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The tuberculosis diagnostics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider tuberculosis diagnostics market; and compares it with other markets.

The report covers the following chapters
  • Introduction and Market Characteristics
Brief introduction to the segmentations covered in the market, definitions and explanations about the tuberculosis diagnostics market.
  • Key Trends
Highlights the major trends shaping the global tuberculosis diagnostics market. This section also highlights likely future developments in the market.
  • Global Market Size and Growth
Global historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional Analysis
Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region.
  • Market Segmentation
Contains the market values (2017-2032) and analysis for for segment by test type, by disease stage and by end user in the market.
  • Regional Market Size and Growth
Regional market size (2022), historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape
Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Key Mergers and Acquisitions
Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies
Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations
This section includes recommendations for tuberculosis diagnostics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix
This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:
1) By Test Type: Radiographic Tests; Nucleic Acid Testing; Cytokine Detection Tests; Drug Resistance Tests; Skin Test / Mantoux Test (TST); Blood/Serology Test; Smear Microscopy Tests; Cell Culture-Based Tests; Other Test Types
2) By Disease Stage: Latent Tuberculosis; Active Tuberculosis
3) By End-User: Hospitals And Diagnostic Laboratories; Physician’s Office Laboratories; Reference Laboratories; Academics And Research Facilities


Companies Mentioned: Beckton, Dickinson and Company; F. Hoffmann-La Roche Ltd; Qiagen N.V; BioMerieux SA; Danaher Corporation (Cepheid Inc.)
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; tuberculosis diagnostics indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Executive Summary
2. Table Of Contents
3. List Of Figures
4. List Of Tables
5. Report Structure
6. Introduction And Market Characteristics
6.1. General Market Definition
6.2. Summary
6.3. Tuberculosis Diagnostics Market Definition And Segmentations
6.4. Market Segmentation By Test Type
6.4.1. Radiographic Test
6.4.2. Nucleic Acid Testing
6.4.3. Cytokine Detection Test
6.4.4. Drug Resistance Test
6.4.5. Skin Test/Mantoux Test (TST)
6.4.6. Blood Test/Serology Test
6.4.7. Smear Microscopy
6.4.8. Cultured-Based Tests
6.4.9. Other Test Types
6.5. Market Segmentation By Disease Stage
6.5.1. Latent Tuberculosis
6.5.2. Active Tuberculosis
6.6. Market Segmentation By End User
6.6.1. Hospitals And Diagnostic Laboratories
6.6.2. Physician’s Office Laboratories
6.6.3. Reference Laboratories
6.6.4. Academics And Research Facilities
7. Major Market Trends
7.1. Next Generation Sequencing (NGS) Platform For TB Diagnostics
7.2. Product Innovations
7.3. T Cell Tests For TB Infection
7.4. Artificial Intelligence (AI)-Based Tuberculosis Diagnostics
7.5. Use Of Portable Devices
7.6. Collaborations Between Governments And Manufacturers
8. Global Market Size and Growth
8.1. Market Size
8.2. Historic Market Growth, 2017 – 2022, Value ($ Million)
8.2.1. Market Drivers 2017 – 2021
8.2.2. Market Restraints 2017 – 2022
8.3. Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
8.3.1. Market Drivers 2022 – 2027
8.3.2. Market Restraints 2022 – 2027
9. Global Tuberculosis Diagnostics Market Segmentation
9.1. Global Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.2. Global Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
9.3. Global Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10. Tuberculosis Diagnostics Market, Regional and Country Analysis
10.1. Global Tuberculosis Diagnostics Market, By Region, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
10.2. Global Tuberculosis Diagnostics Market, By Country, Historic and Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11. Asia-Pacific Market
11.1. Summary
11.2. Market Overview
11.2.1. Region Information
11.2.2. Market Information
11.2.3. Background Information
11.2.4. Government Initiatives
11.2.5. Regulations
11.2.6. Regulatory Bodies
11.2.7. Major Associations
11.2.8. Taxes levied
11.2.9. Corporate Tax Structure
11.2.10. Investments
11.2.11. Major Companies
11.3. Asia-Pacific Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.4. Asia-Pacific Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.5. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.6. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.7. Asia-Pacific Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.8. Asia-Pacific Tuberculosis Diagnostics Market: Country Analysis
11.9. China Market
11.10. Summary
11.11. Market Overview
11.11.1. Country Information
11.11.2. Market Information
11.11.3. Background Information
11.11.4. Government Initiatives
11.11.5. Regulations
11.11.6. Regulatory Bodies
11.11.7. Major Associations
11.11.8. Taxes levied
11.11.9. Corporate tax structure
11.11.10. Investments
11.11.11. Major Companies
11.12. China Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.13. China Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.14. China Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.15. China Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.16. China Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.17. India Market
11.18. India Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.19. India Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.20. India Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.21. India Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.22. India Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.23. Japan Market
11.24. Japan Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.25. Japan Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.26. Japan Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.27. Japan Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.28. Japan Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.29. Australia Market
11.30. Australia Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.31. Australia Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.32. Australia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.33. Australia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.34. Australia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.35. Indonesia Market
11.36. Indonesia Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.37. Indonesia Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.38. Indonesia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.39. Indonesia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.40. Indonesia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.41. South Korea Market
11.42. South Korea Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
11.43. South Korea Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
11.44. South Korea Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.45. South Korea Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
11.46. South Korea Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12. Western Europe Market
12.1. Summary
12.2. Market Overview
12.2.1. Region Information
12.2.2. Market Information
12.2.3. Background Information
12.2.4. Government Initiatives
12.2.5. Regulations
12.2.6. Regulatory Bodies
12.2.7. Major Associations
12.2.8. Taxes levied
12.2.9. Corporate tax structure
12.2.10. Investments
12.2.11. Major Companies
12.3. Western Europe Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.4. Western Europe Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.5. Western Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.6. Western Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.7. Western Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.8. Western Europe Tuberculosis Diagnostics Market: Country Analysis
12.9. UK Market
12.10. UK Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.11. UK Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.12. UK Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.13. UK Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.14. UK Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.15. Germany Market
12.16. Germany Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.17. Germany Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.18. Germany Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.19. Germany Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.20. Germany Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.21. France Market
12.22. France Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
12.23. France Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
12.24. France Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.25. France Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
12.26. France Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13. Eastern Europe Market
13.1. Summary
13.2. Market Overview
13.2.1. Region Information
13.2.2. Market Information
13.2.3. Background Information
13.2.4. Government Initiatives
13.2.5. Regulation
13.2.6. Regulatory Bodies
13.2.7. Major Associations
13.2.8. Taxes Levied
13.2.9. Corporate Tax Structure
13.2.10. Investments
13.2.11. Major Companies
13.3. Eastern Europe Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.4. Eastern Europe Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.5. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.6. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.7. Eastern Europe Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.8. Eastern Europe Tuberculosis Diagnostics Market: Country Analysis
13.9. Russia Market
13.10. Russia Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
13.11. Russia Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
13.12. Russia Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.13. Russia Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
13.14. Russia Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14. North America Market
14.1. Summary
14.2. Market Overview
14.2.1. Region Information
14.2.2. Market Information
14.2.3. Background Information
14.2.4. Government Initiatives
14.2.5. Regulations
14.2.6. Regulatory Bodies
14.2.7. Major Associations
14.2.8. Taxes Levied
14.2.9. Corporate Tax Structure
14.2.10. Investments
14.2.11. Major Companies
14.3. North America Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.4. North America Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.5. North America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.6. North America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.7. North America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.8. North America Tuberculosis Diagnostics Market: Country Analysis
14.9. USA Market
14.10. Summary
14.11. Market Overview
14.11.1. Country Information
14.11.2. Market Information
14.11.3. Background Information
14.11.4. Government Initiatives
14.11.5. Regulations
14.11.6. Regulatory Bodies
14.11.7. Major Associations
14.11.8. Taxes levied
14.11.9. Corporate Tax Structure
14.11.10. Investments
14.11.11. Major Companies
14.12. USA Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
14.13. USA Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
14.14. USA Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.15. USA Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
14.16. USA Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15. South America Market
15.1. Summary
15.2. Market Overview
15.2.1. Region Information
15.2.2. Market Information
15.2.3. Background Information
15.2.4. Government Initiatives
15.2.5. Regulations
15.2.6. Regulatory Bodies
15.2.7. Major Associations
15.2.8. Taxes Levied
15.2.9. Corporate Tax Structure
15.2.10. Investments
15.2.11. Major Companies
15.3. South America Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.4. South America Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.5. South America Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.6. South America Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.7. South America Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.8. South America Tuberculosis Diagnostics Market: Country Analysis
15.9. Brazil Market
15.10. Brazil Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
15.11. Brazil Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
15.12. Brazil Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.13. Brazil Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
15.14. Brazil Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16. Middle East Market
16.1. Summary
16.2. Market Overview
16.2.1. Region Information
16.2.2. Market Information
16.2.3. Background Information
16.2.4. Government Initiatives
16.2.5. Regulations
16.2.6. Regulatory Bodies
16.2.7. Major Associations
16.2.8. Taxes Levied
16.2.9. Corporate Tax Structure
16.2.10. Investments
16.2.11. Major Companies
16.3. Middle East Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
16.4. Middle East Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
16.5. Middle East Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.6. Middle East Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
16.7. Middle East Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17. Africa Market
17.1. Summary
17.2. Market Overview
17.2.1. Region Information
17.2.2. Market Information
17.2.3. Background Information
17.2.4. Government Initiatives
17.2.5. Regulations
17.2.6. Regulatory Bodies
17.2.7. Major Associations
17.2.8. Taxes Levied
17.2.9. Corporate Tax Structure
17.2.10. Investments
17.2.11. Major Companies
17.3. Africa Tuberculosis Diagnostics Market, Historic Market Growth, 2017 – 2022, Value ($ Million)
17.4. Africa Tuberculosis Diagnostics Market, Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
17.5. Africa Tuberculosis Diagnostics Market, Segmentation By Test Type, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.6. Africa Tuberculosis Diagnostics Market, Segmentation By Disease Stage, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
17.7. Africa Tuberculosis Diagnostics Market, Segmentation By End User, Historic And Forecast, 2017 – 2022, 2027F, 2032F, Value ($ Million)
18. Competitive Landscape and Company Profiles
18.1. Company Profiles
18.2. Becton Dickinson and Company (BD)
18.2.1. Company Overview
18.2.2. Products And Services
18.2.3. Business Strategy
18.2.4. Financial Overview
18.3. F. Hoffmann-La Roche Ltd
18.3.1. Company Overview
18.3.2. Products And Services
18.3.3. Business Strategy
18.3.4. Financial Overview
18.4. Qiagen N.V.
18.4.1. Company Overview
18.4.2. Products And Services
18.4.3. Business Strategy
18.4.4. Financial Overview
18.5. BioMerieux SA
18.5.1. Company Overview
18.5.2. Products And Services
18.5.3. Business Strategy
18.5.4. Financial Overview
18.6. Danaher Corporation
18.6.1. Company Overview
18.6.2. Products And Services
18.6.3. Business Strategy
18.6.4. Financial Overview
19. Key Mergers And Acquisitions
19.1. Molbio Diagnostics Pvt. Ltd. Acquired Prognosys Medical Systems
19.2. Fujifilm Collaborated with Qure.ai
19.3. SD Biosensor Inc. Acquired Relab Srl
19.4. Roche Acquired GenMark Diagnostics
19.5. PerkinElmer Acquired Oxford Immunotec
20. Opportunities And Strategies
20.1. Global Tuberculosis Diagnostics Market In 2027 – Countries Offering Most New Opportunities
20.2. Global Tuberculosis Diagnostics Market In 2027 – Segments Offering Most New Opportunities
20.3. Global Tuberculosis Diagnostics Market In 2027 – Growth Strategies
20.3.1. Market Trend Based Strategies
20.3.2. Competitor Strategies
21. Tuberculosis Diagnostics Market, Conclusions And Recommendations
21.1. Conclusions
21.2. Recommendations
21.2.1. Product
21.2.2. Place
21.2.3. Price
21.2.4. Promotion
21.2.5. People
22. Appendix
22.1. Market Data Sources
22.2. Research Methodology
22.3. Currencies
22.4. The Business Research Company
22.5. Copyright and Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings